Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1992-04-30
1993-11-23
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
548518, 548542, 5483001, 514422, 514424, 514385, 436173, 1286534, G01N 2408, A61K 3140, A61K 31415
Patent
active
052642046
ABSTRACT:
Methods and compositions are disclosed for enhancing magnetic resonance imaging which utilize hydrophilic free radical compounds as magnetic resonance contrast media. Typical magnetic resonance contrast media within the scope of the present invention include stable hydrophilic free radicals having a hydrophilic moiety, such as polyhydroxyalkyl groups and heterocyclic amino-alcohols such as dihydroxypyrrolidine, dihydroxypiperidine, and trihydroxypiperidine, and a stable free radical moiety, such as a nitroxide, phenoxy, or phenoxazinyl free radical moiety.
REFERENCES:
patent: 3502692 (1970-03-01), Feldman et al.
patent: 4834964 (1989-05-01), Rosen
patent: 4845090 (1989-07-01), Gries et al.
patent: 4925652 (1990-05-01), Gries et al.
patent: 5104641 (1992-04-01), Rosen
Brasch, RC AJR 141:1019-1023 (1983).
W. R. Couet et al., "Factors Affecting Nitroxide Reduction in Ascorbate Solution and Tissue Homogenates", Magnetic Resonance Imaging, vol. 3, pp. 83-88, 1985.
Cacheris William P.
deLearie Lynn
Dunn T. Jeffrey
Levine Jeffrey A.
Lin Youlin
Hollinden Gary E.
Hollrah Glennon H.
Mallinckrodt Medical Inc.
LandOfFree
Hydrophilic free radicals for magnetic resonance imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrophilic free radicals for magnetic resonance imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrophilic free radicals for magnetic resonance imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1846792